Noncommunicable diseases (NCDs), particularly diabetes and hypertension, are increasing drivers of mortality in low-income countries. In Haiti, cardiovascular disease surpassed HIV as the leading cause of adult death. Before this initiative, the isolated Grand'Anse Department lacked a dedicated chronic disease facility. The Centre Dr. René Charles was established in Jérémie to deliver structured care for people with diabetes and hypertension and to document initial implementation and clinical outcomes over 24 months.
This report describes a retrospective single-center cohort study covering April 2024 through March 2026. The analysis included 1,298 clinic encounters among 590 patients seen at the dedicated diabetes and hypertension clinic. Longitudinal change over calendar time was modeled using linear mixed-effects models, and paired first-to-last comparisons supplemented those models. The report is a preprint and has not been peer reviewed; the authors note that findings should not be used to guide clinical practice without further validation.
The cohort was 74.1% female with a mean age of 58.2 years. Educational attainment was low: nearly two thirds of patients had only primary-level education or no formal schooling. Diagnostic categories at presentation were: hypertension alone in 52.9% of patients, combined diabetes and hypertension in 26.8%, and diabetes alone in 20.3%.
Standardized assessments employed at the clinic included serial blood pressure measurements, fasting glucose, HbA1c, lipid profiles, renal indices, and electrocardiography. Some tests were performed based on clinical indication rather than systematically for every patient; the authors highlight that this selective testing affects interpretation of apparent rates of end-organ damage in the cohort.
Establishing the clinic in this resource-limited rural setting proved operationally feasible. However, early attrition emerged as a major challenge: 54% of patients attended only once during the 24-month period. Analyses of clinical change were therefore concentrated on the subset of patients who returned for follow-up visits; the authors frame longitudinal outcome estimates as exploratory and hypothesis-generating given this selective follow-up.
Among patients with hypertension who returned, mixed-effects models on calendar time estimated a decline in systolic blood pressure of 0.78 mmHg per month (95% CI, 0.36 to 1.21; P = 0.005). Paired comparisons from the first to the last visit showed a mean systolic blood pressure fall of 9.0 mmHg (P < 0.001). The proportion meeting blood pressure control rose from 21.4% at first measurement to 38.1% at the last measurement among returners (P < 0.001). These improvements are reported only for patients with follow-up and should not be interpreted as cohort-wide effects given the high single-visit rate.
Glycemic control did not show durable improvement across the returning subset. Although paired fasting glucose measurements demonstrated a large decline (52.5 mg/dL) and a borderline trend over time (P = 0.05), mean HbA1c among patients remained elevated at 10.4%. Only 13.2% of patients achieved the HbA1c target used by the investigators. The authors note that these glycemic results are limited to those with follow-up testing and may reflect access, retention, and treatment constraints.
Indication-driven screening of a clinically selected minority frequently detected evidence of end-organ damage. The report emphasizes that these findings reflect selective, clinically indicated testing rather than prevalence estimates for the whole clinic population. Details on the absolute numbers and types of detected organ damage were not reported in the abstract.
The experience demonstrates that a dedicated NCD clinic can be implemented in a highly resource-limited, rural Haitian department that previously lacked such services. Early retention is the central operational challenge identified. The authors prioritize improving patient retention, expanding medication access, and securing durable health-system investment to support ongoing chronic disease management and to achieve more consistent improvements in outcomes, particularly glycemic control.
The study is retrospective and single-center, and the large proportion of patients who attended only once limits generalizability of longitudinal outcome estimates. Analyses of change are restricted to returners and are therefore exploratory. Aggregate de-identified data underlying figures and summary statistics are publicly available on Zenodo; the patient-level clinical registry contains potentially identifying data and is accessible to qualified researchers on request to FHADIMAC.
A dedicated diabetes and hypertension clinic was feasible to establish in Jérémie, Grand'Anse, and early within-patient data among returners suggest measurable blood pressure improvements. Persistent high mean HbA1c and low rates of glycemic control underline the need for better retention, medication access, and sustained system-level investment. The authors present the results as hypothesis-generating and call for further work to address attrition and to evaluate scalable interventions in similar resource-limited settings.